Literature DB >> 25790314

Mildly Reduced Brain Swelling and Improved Neurological Outcome in Aquaporin-4 Knockout Mice following Controlled Cortical Impact Brain Injury.

Xiaoming Yao1,2, Kazuyoshi Uchida1, Marios C Papadopoulos3, Zsolt Zador1, Geoffrey T Manley1, Alan S Verkman2.   

Abstract

Brain edema following traumatic brain injury (TBI) is associated with considerable morbidity and mortality. Prior indirect evidence has suggested the involvement of astrocyte water channel aquaporin-4 (AQP4) in the pathogenesis of TBI. Here, focal TBI was produced in wild type (AQP4(+/+)) and knockout (AQP4(-/-)) mice by controlled cortical impact injury (CCI) following craniotomy with dura intact (parameters: velocity 4.5 m/sec, depth 1.7 mm, dwell time 150 msec). AQP4-deficient mice showed a small but significant reduction in injury volume in the first week after CCI, with a small improvement in neurological outcome. Mechanistic studies showed reduced intracranial pressure at 6 h after CCI in AQP4(-/-) mice, compared with AQP4(+/+) control mice (11 vs. 19 mm Hg), with reduced local brain water accumulation as assessed gravimetrically. Transmission electron microscopy showed reduced astrocyte foot-process area in AQP4(-/-) mice at 24 h after CCI, with greater capillary lumen area. Blood-brain barrier disruption assessed by Evans blue dye extravasation was similar in AQP4(+/+) and AQP4(-/-) mice. We conclude that the mildly improved outcome in AQP4(-/-) mice following CCI results from reduced cytotoxic brain water accumulation, though concurrent cytotoxic and vasogenic mechanisms in TBI make the differences small compared to those seen in disorders where cytotoxic edema predominates.

Entities:  

Keywords:  AQP4; brain edema; brain trauma; controlled cortical impact injury; cytotoxic edema

Mesh:

Substances:

Year:  2015        PMID: 25790314      PMCID: PMC4589265          DOI: 10.1089/neu.2014.3675

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  43 in total

1.  Distinguishing between cellular and vasogenic edema in head injured patients with focal lesions using magnetic resonance imaging.

Authors:  A Marmarou; G Portella; P Barzo; S Signoretti; P Fatouros; A Beaumont; T Jiang; R Bullock
Journal:  Acta Neurochir Suppl       Date:  2000

Review 2.  New roles for astrocytes: redefining the functional architecture of the brain.

Authors:  Maiken Nedergaard; Bruce Ransom; Steven A Goldman
Journal:  Trends Neurosci       Date:  2003-10       Impact factor: 13.837

3.  Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.

Authors:  Ludmila Belayev; Larissa Khoutorova; Theresa A Deisher; Andrey Belayev; Raul Busto; Yongbo Zhang; Weizhao Zhao; Myron D Ginsberg
Journal:  Stroke       Date:  2003-02-06       Impact factor: 7.914

4.  Decreased hemispheric Aquaporin-4 is linked to evolving brain edema following controlled cortical impact injury in rats.

Authors:  Karl L Kiening; Frank K H van Landeghem; Stefan Schreiber; Ulrich W Thomale; Andreas von Deimling; Andreas W Unterberg; John F Stover
Journal:  Neurosci Lett       Date:  2002-05-17       Impact factor: 3.046

5.  Neuroprotective effect of aquaporin-4 deficiency in a mouse model of severe global cerebral ischemia produced by transient 4-vessel occlusion.

Authors:  Gökhan Akdemir; Julien Ratelade; Nithi Asavapanumas; A S Verkman
Journal:  Neurosci Lett       Date:  2014-04-06       Impact factor: 3.046

6.  Characterizing edema associated with cortical contusion and secondary insult using magnetic resonance spectroscopy.

Authors:  G Portella; A Beaumont; F Corwin; P Fatouros; A Marmarou
Journal:  Acta Neurochir Suppl       Date:  2000

7.  An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain.

Authors:  Mahmood Amiry-Moghaddam; Takashi Otsuka; Patricia D Hurn; Richard J Traystman; Finn-Mogens Haug; Stanley C Froehner; Marvin E Adams; John D Neely; Peter Agre; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

8.  AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury.

Authors:  Efthimios Dardiotis; Konstantinos Paterakis; Georgios Tsivgoulis; Magdalini Tsintou; Georgios F Hadjigeorgiou; Maria Dardioti; Savas Grigoriadis; Constantina Simeonidou; Apostolos Komnos; Eftychia Kapsalaki; Kostas Fountas; Georgios M Hadjigeorgiou
Journal:  J Neurotrauma       Date:  2014-10-10       Impact factor: 5.269

9.  Regulation of aquaporin-4 in a traumatic brain injury model in rats.

Authors:  Ming-Chieh Sun; Christopher R Honey; Caglar Berk; Norman L M Wong; Joseph K C Tsui
Journal:  J Neurosurg       Date:  2003-03       Impact factor: 5.115

10.  Greatly improved survival and neuroprotection in aquaporin-4-knockout mice following global cerebral ischemia.

Authors:  Ryuichi Katada; Gokhan Akdemir; Nithi Asavapanumas; Julien Ratelade; Hua Zhang; A S Verkman
Journal:  FASEB J       Date:  2013-11-01       Impact factor: 5.191

View more
  26 in total

Review 1.  A Precision Medicine Approach to Cerebral Edema and Intracranial Hypertension after Severe Traumatic Brain Injury: Quo Vadis?

Authors:  Ruchira M Jha; Patrick M Kochanek
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-07       Impact factor: 5.081

2.  Functionalized Phenylbenzamides Inhibit Aquaporin-4 Reducing Cerebral Edema and Improving Outcome in Two Models of CNS Injury.

Authors:  George W Farr; Christopher H Hall; Susan M Farr; Ramon Wade; Joshua M Detzel; Amielia G Adams; Jasen M Buch; Derek L Beahm; Christopher A Flask; Kui Xu; Joseph C LaManna; Paul R McGuirk; Walter F Boron; Marc F Pelletier
Journal:  Neuroscience       Date:  2019-02-07       Impact factor: 3.590

3.  Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury.

Authors:  Ruchira M Jha; Ava M Puccio; Sherry Hsiang-Yi Chou; Chung-Chou H Chang; Jessica S Wallisch; Bradley J Molyneaux; Benjamin E Zusman; Lori A Shutter; Samuel M Poloyac; Keri L Janesko-Feldman; David O Okonkwo; Patrick M Kochanek
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

Review 4.  Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced Neurodegeneration.

Authors:  Danielle K Sandsmark; Asma Bashir; Cheryl L Wellington; Ramon Diaz-Arrastia
Journal:  Neuron       Date:  2019-08-07       Impact factor: 17.173

Review 5.  The Medical Management of Cerebral Edema: Past, Present, and Future Therapies.

Authors:  Michael R Halstead; Romergryko G Geocadin
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  ABCC8 Single Nucleotide Polymorphisms are Associated with Cerebral Edema in Severe TBI.

Authors:  Ruchira M Jha; Ava M Puccio; David O Okonkwo; Benjamin E Zusman; Seo-Young Park; Jessica Wallisch; Philip E Empey; Lori A Shutter; Robert S B Clark; Patrick M Kochanek; Yvette P Conley
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

Review 7.  Pathophysiology and treatment of cerebral edema in traumatic brain injury.

Authors:  Ruchira M Jha; Patrick M Kochanek; J Marc Simard
Journal:  Neuropharmacology       Date:  2018-08-04       Impact factor: 5.250

8.  Glibenclamide Produces Region-Dependent Effects on Cerebral Edema in a Combined Injury Model of Traumatic Brain Injury and Hemorrhagic Shock in Mice.

Authors:  Ruchira M Jha; Bradley J Molyneaux; Travis C Jackson; Jessica S Wallisch; Seo-Young Park; Samuel Poloyac; Vincent A Vagni; Keri L Janesko-Feldman; Keito Hoshitsuki; M Beth Minnigh; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2018-06-06       Impact factor: 5.269

9.  Aquaporin-4 is a potential drug target for traumatic brain injury via aggravating the severity of brain edema.

Authors:  Ao Xiong; Renping Xiong; Jing Yu; Yijia Liu; Ke Liu; Ge Jin; Jianzhong Xu; Jun Yan
Journal:  Burns Trauma       Date:  2021-03-15

10.  Cerebral Edema in Traumatic Brain Injury: a Historical Framework for Current Therapy.

Authors:  Benjamin E Zusman; Patrick M Kochanek; Ruchira M Jha
Journal:  Curr Treat Options Neurol       Date:  2020-03-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.